• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinical comparison of Hexabrix, iopamidol, and Urografin-60 in whole body computed tomography.

作者信息

Spataro R F, Fischer H W, Kormano M

出版信息

Invest Radiol. 1984 Nov-Dec;19(6 Suppl):S372-5. doi: 10.1097/00004424-198411001-00028.

DOI:10.1097/00004424-198411001-00028
PMID:6511276
Abstract

Urografin 60, iopamidol and Hexabrix were studied in patients undergoing body CT scans to examine the pharmacodynamics of these contrast agents. Immediately following rapid injection, the lower osmolality media, Hexabrix and iopamidol, gave greater aortic concentration of iodine in addition to higher concentrations in the liver and spleen. These two agents also provided significantly better renal enhancement than Urografin 60, with Hexabrix giving higher levels than iopamidol. The higher early vascular concentrations of Hexabrix and iopamidol and the relative absence of side effects due to hyperosmolality and decreased toxicity may have advantages in dynamic CT scanning.

摘要

相似文献

1
Clinical comparison of Hexabrix, iopamidol, and Urografin-60 in whole body computed tomography.
Invest Radiol. 1984 Nov-Dec;19(6 Suppl):S372-5. doi: 10.1097/00004424-198411001-00028.
2
Comparison of diatrizoate, iopamidol, and ioxaglate for the contrast enhancement of experimental hepatic tumors in CT.
Invest Radiol. 1985 Sep;20(6):626-31. doi: 10.1097/00004424-198509000-00018.
3
Contrast enhancement pharmacokinetics of six ionic and nonionic contrast media.六种离子型和非离子型造影剂的对比增强药代动力学
Invest Radiol. 1983 Jul-Aug;18(4):368-74. doi: 10.1097/00004424-198307000-00015.
4
Urography with low-osmolality contrast media: comparative urinary excretion of Iopamidol, Hexabrix, and diatrizoate.
Invest Radiol. 1982 Sep-Oct;17(5):494-500. doi: 10.1097/00004424-198209000-00010.
5
Excretion of contrast media by the immature rabbit. Comparison of Renografin and Iopamidol.
Invest Radiol. 1984 Mar-Apr;19(2):123-8.
6
Double-blind comparison of Hexabrix and Renografin-76 in computed tomography.
Invest Radiol. 1984 Nov-Dec;19(6 Suppl):S376-7. doi: 10.1097/00004424-198411001-00029.
7
A double-blind clinical study comparing the safety and efficacy of Hexabrix and Renografin-76 in contrast enhanced computed body tomography.一项比较Hexabrix和泛影葡胺-76在对比增强计算机体层摄影术中安全性和有效性的双盲临床研究。
Invest Radiol. 1984 Nov-Dec;19(6 Suppl):S378-84. doi: 10.1097/00004424-198411001-00030.
8
Patient tolerance to sequential administration of Urografin and Hexabrix.患者对优维显和泛影葡胺序贯给药的耐受性。
Br J Radiol. 1985 Mar;58(687):272. doi: 10.1259/0007-1285-58-687-272.
9
Dynamic contrast enhancement of the upper abdomen: effect of contrast medium and body weight.上腹部动态对比增强:造影剂和体重的影响
Invest Radiol. 1983 Jul-Aug;18(4):364-7. doi: 10.1097/00004424-198307000-00013.
10
Pharmacokinetics of contrast media: experimental results in dog and man with CT implications.
J Comput Assist Tomogr. 1980 Apr;4(2):178-85.